Attached files
| file | filename |
|---|---|
| 8-K - 8-K - T2 Biosystems, Inc. | d581474d8k.htm |
Exhibit 16.1
June 13, 2018
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated June 13, 2018, of T2 Biosystems, Inc. and are in agreement with the statements contained in the first, third, fourth and fifth paragraphs on page 2 therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
Regarding the registrant’s statement concerning the lack of internal control to prepare financial statements, included in the fourth paragraph on page 2 therein, we had considered such matter in determining the nature, timing and extent of procedures performed in our audit of the registrant’s 2017 financial statements.
| /s/ Ernst & Young LLP |